⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4391191 | 0.65 | — | — | |
| SCHEMBL15238080 | 0.61 | — | — | |
| SCHEMBL1819677 | 0.60 | — | — | |
| SCHEMBL13867351 | 0.58 | — | — | |
| SCHEMBL9033497 | 0.58 | — | — | |
| SCHEMBL15238084 | 0.55 | — | — | |
| SCHEMBL12360467 | 0.55 | — | — | |
| SCHEMBL15062331 | 0.55 | CYP2D6 (0.30) | — | |
| SCHEMBL9886121 | 0.55 | — | — | |
| SCHEMBL15705702 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400497-A1 | 3CLPRO PROTEASE INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024133815-A1 | ANTIBODY-DRUG CONJUGATES WITH MASKED PBD DIMERS | SYNAFFIX B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| EP-4389152-A1 | CONJUGATES OF PBD PRODRUGS | Synaffix B.V. (NL) | 2024-06-26 | — | — | EP | disclosed |
| CN-113376965-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376963-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376962-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376964-B | Coloring composition and compound | 住友化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| US-20230355791-A1 | GLYCAN-CONJUGATED ANTIBODIES BINDING TO FC-GAMMA RECEPTOR | SYNAFFIX B.V. (NL) | 2023-11-09 | — | — | US | disclosed |
| US-20230355791-A1 | GLYCAN-CONJUGATED ANTIBODIES BINDING TO FC-GAMMA RECEPTOR | SYNAFFIX B.V. (NL) | 2023-11-09 | — | — | US | disclosed |
| CN-108693701-B | Colored curable resin composition | 住友化学株式会社 | 2023-07-04 | — | — | CN | disclosed |
| US-20070275962-A1 | Heterobicyclic Compounds as Pharmaceutically Active Agents | GPC BIOTECH AG (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20070275962-A1 | Heterobicyclic Compounds as Pharmaceutically Active Agents | GPC BIOTECH AG (DE) | 2007-11-29 | — | — | US | disclosed |
| WO-2007060028-A1 | NAPTHYRIDINE COMPOUNDS AS ROCK INHIBITORS | GPC BIOTECH AG (DE) | 2007-05-31 | — | — | WO | disclosed |
| EP-1757607-A1 | N5-substituted benzo¬2,3|azepino¬4,5-b|indol-6-ones for treating tropical diseases | Molisa GmbH (DE) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005023818-A2 | HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS | GPC BIOTECH AG (DE) | 2005-03-17 | — | — | WO | disclosed |
| EP-0358758-A1 | B LYMPHOCYTE SEPARATING MATERIAL AND BODY FLUID CLARIFYING MATERIAL | TERUMO KABUSHIKI KAISHA (JP) | 1990-03-21 | — | — | EP | disclosed |
| EP-0197521-B1 | IMMUNOGLOBULIN ADSORBENT AND ADSORPTION APPARATUS | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1989-08-02 | — | — | EP | disclosed |
| EP-0273265-A1 | Substituted N-methylisoxazolidines | BAYER AG (DE) | 1988-07-06 | — | — | EP | disclosed |
| US-4705628-A | SILICA GEL REACTED WITH DIAMINE, SILANE COUPLER, SULFA DRUG | TERUMO KABUSHIKI KAISHA (JP) | 1987-11-10 | — | — | US | disclosed |
| EP-0197521-A2 | Immunoglobulin adsorbent and adsorption apparatus | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1986-10-15 | — | — | EP | disclosed |